Who Answers
Who Answers
DrugRehab.ca's Phone Number
Who Answers

Our phone line is staffed by knowledgeable rehab specialists ready to assist you. From 9:00 AM to 4:00 PM, Monday to Friday, and all day Sunday, a specialist from DRS will answer your calls. Outside these hours, your calls will be handled by a rehab specialist from “Together We Can,” a treatment facility in BC, ensuring you receive support whenever you need it.

HomeArticlesDrug Treatment Option ResourcesInpatient Treatment ResourcesShort-Term vs. Long-Term Inpatient Rehab Programs in Canada

Short-Term vs. Long-Term Inpatient Rehab Programs in Canada

When considering inpatient addiction treatment in Canada, one of the first practical questions is program length: a 21-day program, a 28-day program, a 60-day program, or something longer. The range is wide, the costs and time commitments vary significantly, and the guidance available, both in promotional materials and in some clinical resources, does not always make the basis for these differences clear.

An important framing point at the outset: program duration is one dimension of quality, not the most important one. What happens inside a program, the strength of its assessment process, whether it addresses co-occurring mental health conditions, and whether it connects to a structured plan for continuing care after discharge, all shape outcomes alongside how long a program runs. Duration matters in context. On its own, it tells you less than you might expect.

What Short-Term and Long-Term Actually Mean

Canadian inpatient addiction treatment programs do not have standardised duration categories defined in regulation or clinical guidelines, so the terms “short-term” and “long-term” are used inconsistently across the sector. For the purposes of this article, programs of 30 days or less are considered short-term, and programs of more than 30 days are considered long-term. This reflects how the distinction is most commonly understood in addiction treatment generally, even though individual programs and provinces may use the terms differently.

  • Short-term programs typically run for three to four weeks. The CCSA’s In-Patient Treatment for Substance Use in Canada guide notes that most inpatient programs are live-in programs of at least 21 consecutive days, and CAMH’s treatment guidance notes that most residential programs involve a three- to six-week stay. Programs at the shorter end of that range, up to 30 days, fall into the short-term category.
  • Long-term programs cover a wide span, from programs just over a month to extended therapeutic communities that run six months to a year or more. People who choose or are recommended longer programs often have more complex presentations: a longer history of substance use, prior treatment that did not lead to lasting change, co-occurring mental health conditions, or significant instability in their housing or social circumstances. Within this broad category, there is real variation in structure and intensity, and what a six-week program looks like is quite different from what a nine-month therapeutic community looks like.

The lack of standardisation means that program length alone does not tell you everything about what a program offers. Two programs both labelled “long-term” can differ significantly in their approach, staffing, and the specific population they are built to serve.

Who Needs Residential Treatment?

Before addressing duration, it is worth clarifying who inpatient treatment is appropriate for at all. The CCSA’s In-Patient Treatment for Substance Use in Canada guide is direct on this point: in-patient treatment is not for everyone. CAMH’s treatment guidance adds that community treatment programs are effective for socially stable patients with less severe substance use problems, and outpatient care is often the appropriate starting point for people who do not need residential structure to engage with treatment.

CAMH states that patients diagnosed with a moderate to severe substance use disorder should consider residential treatment, and identifies three groups for whom it is particularly appropriate: people who have not succeeded in community-based treatment, people who require medical management of withdrawal, and people living in a chaotic or unsupportive home environment.

The CCSA’s guide reinforces the broader point that in-patient treatment is one of many options available and is not necessarily the best fit for everyone. Outpatient programs, the guide notes, may be more readily available, including through virtual care, more affordable, and better suited to some people’s circumstances than in-patient treatment.

What the Evidence Says About Treatment Duration

Across our sources, a consistent theme emerges: duration should be matched to the person’s situation, not chosen first and fit to the person afterward.

The CCSA’s guide is direct that how long a person stays in an inpatient treatment program depends on the program and their needs. CAMH’s clinical guidance reflects a similar individualised logic in how it frames who residential treatment suits: people who have not succeeded in community-based treatment, who need medical management of withdrawal, or whose home environment is chaotic or unsupportive. None of this points to a single ideal duration. It points to matching the setting and length of treatment to what a person’s circumstances actually require.

What is also clear from the CCSA’s guide is that the period after residential treatment matters. Discharge and aftercare planning should begin early, not as an afterthought near the end of a stay. Programs vary considerably in what aftercare they offer, and that variation is worth asking about directly when evaluating any program, regardless of how long the residential portion runs.

Matching Program Length to Individual Need

The following factors, drawn from CCSA’s in-patient treatment guide and CAMH’s clinical guidance, are relevant in thinking about what program length might suit a given person.

Severity and History of Substance Use

Someone with a longer history of heavy use, more significant physical and psychological dependence, and prior treatment episodes may benefit from a longer residential stay than someone earlier in the course of their substance use disorder. This is consistent with the general clinical principle that more severe presentations often call for more intensive intervention.

Concurrent Disorders

When a substance use disorder co-occurs with significant mental health conditions such as depression, PTSD, psychosis, or personality disorders, CAMH notes that the best outcomes come from addressing both conditions at the same time, in a coordinated way. This kind of integrated treatment can take longer to deliver well, since it involves stabilising both conditions and developing a coordinated approach between them rather than treating substance use in isolation.

Environmental Stability

A person returning to a stable, supportive environment after treatment can often step down to outpatient or community continuing care relatively quickly. A person returning to an environment with ongoing substance use by others, housing instability, or other serious stressors may need a longer residential stay to build stability and skills before facing that environment again. Program length should account for where a person is going as well as where they have been.

Prior Treatment History

Someone entering their first treatment episode may do well in a shorter program, particularly with strong motivation and good social support. Someone with multiple prior treatment episodes may benefit from longer engagement or a more specialised program, and treatment planning should account for that history rather than treating it as a setback.

Our Perspective on Treatment Length

As a general editorial position, and not a claim about every individual case, we believe that longer residential treatment tends to give people a meaningfully better chance at lasting recovery. This is not because longer is inherently better in some absolute sense, and it does not mean every long-term program outperforms every short-term one. It is because the underlying work of recovery, understanding what drove the substance use and building real tools to handle triggers and difficult emotions differently, takes time. A short-term program can begin that work and, for some people, that is genuinely enough. But doing that work thoroughly, with enough time to practice new tools in a structured setting before facing the outside world again, is harder to achieve in three or four weeks than it is in two or three months.

This is our perspective, not a claim that any specific program length is clinically necessary for any specific person. The right length of treatment depends on the individual: their history, their support system, their co-occurring conditions, and what they are realistically able to commit to. But as a broad, general principle, more time spent doing the deeper work of recovery, with proper support throughout, tends to produce a sturdier foundation than less time doing the same work.

Cost in Canada: Public vs. Private and What Duration Means for Each

The CCSA’s guide is direct that Canada has both publicly and privately funded in-patient treatment programs, and that the cost of publicly funded programs is covered by social assistance in most, though not all, provinces and territories.

Publicly funded residential programs are generally accessed through provincial health authority addiction services, and they tend to sit on the shorter end of the duration spectrum. Availability varies significantly by province and region, and wait lists are common: it is often not possible to get into a program right away, which is why the CCSA’s guide suggests applying to more than one program and accessing outpatient support in the meantime.

Private residential programs are typically not covered by provincial health insurance, though some costs may be recoverable through workplace extended health benefits. They tend to offer longer durations and more flexibility around start dates than publicly funded options. Private programs can be expensive, and cost is one of the most important practical factors to weigh when considering this route.

Cost and funding source are not reliable indicators of quality on their own. The CCSA makes this point directly: quality of care is available in both publicly and privately funded treatment centres. A person considering private treatment, regardless of duration, should apply the same evaluation questions as they would to any program: the strength of the assessment process, the therapies offered, staff credentials, capacity to treat concurrent disorders, and continuing care planning.

Neither public nor private treatment is inherently better or worse. But there is one practical consideration worth naming honestly: getting into treatment quickly can matter, sometimes urgently, and publicly funded programs cannot always offer that given how common wait lists are. Private treatment can sometimes provide faster access, for those who are able to manage the cost. This is not a reason to avoid publicly funded treatment, which remains the right and often the only accessible option for many people, and is not a lesser path. It simply means that when timing is critical, private treatment is sometimes the more realistic way to get help quickly, for those who can find a way to afford it.

What Comes After: Continuing Care Matters as Much as the Program Itself

Discharge from inpatient treatment is a transition point, and the CCSA’s guide treats what happens at and after that point as a real priority, not an afterthought. The guide is direct that it is never too early to start thinking about the services and support a person will need after completing and being discharged from a program. Quality programs build discharge and aftercare planning into the residential stay early on, treating it as a clinical priority rather than an administrative step at the end.

CAMH’s treatment guidance notes that most residential programs provide regular aftercare group sessions for six months to a year after a person completes inpatient treatment. That extended window reflects how much of the work of recovery happens after the residential stay ends, not just during it.

The practical implication: when evaluating a program, ask specifically about continuing care. Does the program have a structured aftercare component? Does it actively facilitate referrals to outpatient care, peer support, and community services? Does it maintain contact with former residents? These questions matter as much as the length of the program itself.

Recurrence Is a Feature of Addiction, Not Program Failure

The CCSA’s guide addresses recurrence directly: a person may choose to return to the same or a different in-patient treatment program throughout their well-being journey. Many people return to treatment more than once. That is not a sign of failure on the part of the person or, necessarily, the program. It reflects the reality that recovery from a chronic, relapsing condition often unfolds over more than one attempt.

That said, recurrence can sometimes be a useful signal that a particular program or approach was not the right fit, rather than evidence that nothing will work. If someone has tried several short-term or outpatient programs without lasting change, that pattern may point toward trying a longer residential program next time, where there is more time to do the deeper work. If a particular approach, twelve-step programs, for example, did not resonate with someone, that may be worth noting too: a person who struggled to connect with one model might find more traction with cognitive behavioural therapy, a therapeutic community, or another approach entirely. Recurrence can also be useful information, worth discussing honestly with a treatment provider, about what to try differently next time.

The right program is the one that fits the person and has a real plan for what comes next. When comparing inpatient programs, ask about the assessment process, the therapies offered, concurrent disorder capacity, staff credentials, and the continuing care plan. These dimensions of quality shape outcomes more reliably than duration on its own.

Choosing What’s Right for You

There is no single correct answer to how long inpatient treatment should last. The right length depends on the severity and history of the substance use, whether there are co-occurring mental health conditions, what kind of environment a person is returning to, what they have already tried, and what they can realistically access and complete.

What matters most is finding a program with a thorough assessment process that addresses co-occurring conditions alongside the substance use, and a concrete plan for continuing care after discharge. A shorter program done well, with strong continuing care behind it, can be exactly the right choice. So can a longer one, for someone whose history and circumstances call for more time.

If a program did not work in the past, that is not the end of the story. It may simply mean that a different length, a different approach, or a different kind of support is worth trying next. Recovery is rarely a single attempt that resolves everything at once, and there is nothing unusual or shameful about needing more than one.

If you or someone you care about is weighing inpatient treatment options, talking to a family doctor, an addiction counsellor, or a local community health centre is a good place to start working through what fits. The right program is out there, even if it takes more than one try to find it.

Continue Reading